Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2011
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteersEva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos, et al.Clinical Kidney Journal|September 24, 2025
Predicting prognosis in ANCA-associated vasculitis with kidney involvementChristian Maalouli, Selda Aydin, Alix Collard, et al.Internal and Emergency Medicine|November 3, 2025
Point-of-care ultrasound diagnostic accuracy for fecal impaction in the emergency department: a prospective studyFlorence Dupriez, Julie Tollet, Hortense Nely, et al.Pediatrics|September 5, 2006
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of ageTerry Nolan, Henry Bernstein, Mark M Blatter, et al.Journal of Immunological Methods|September 17, 2014
Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patientsPatricia Bourguignon, Frédéric Clément, Frédéric Renaud, et al.Vaccine|October 23, 2013
Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled studyThomas Harrer, Andreas Plettenberg, Keikawus Arastéh, et al.The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United StatesAlexander C Schmidt, Leyi Lin, Luis J Martinez, et al.Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.The Pediatric Infectious Disease Journal|July 29, 2006
Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccineJuan C Tejedor, Manuel Moro, Jesus Ruiz-Contreras, et al.The Pediatric Infectious Disease Journal|January 2, 2007
Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-tetanus toxoid conjugate vaccine coadministered with a Diphtheria-tetanus-acellular Pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 monthsJuan C Tejedor, Manuel Moro, Jesús Ruiz-Contreras, et al.Pageof 3